Your browser doesn't support javascript.
loading
Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER.
Joshua, Anthony M; Armstrong, Andrew; Crumbaker, Megan; Scher, Howard I; de Bono, Johann; Tombal, Bertrand; Hussain, Maha; Sternberg, Cora N; Gillessen, Silke; Carles, Joan; Fizazi, Karim; Lin, Ping; Duggan, William; Sugg, Jennifer; Russell, David; Beer, Tomasz M.
Afiliação
  • Joshua AM; Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, NSW, Australia. Electronic address: anthony.joshua@svha.org.au.
  • Armstrong A; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA.
  • Crumbaker M; Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, NSW, Australia.
  • Scher HI; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • de Bono J; The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK.
  • Tombal B; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Hussain M; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
  • Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, Meyer Cancer Center, New York, NY, USA.
  • Gillessen S; Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
  • Carles J; Vall D'Hebron University Hospital, Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Fizazi K; Institut Gustave Roussy, University of Paris Saclay, Villejuif, France.
  • Lin P; Formerly of Pfizer Inc., San Francisco, CA, USA.
  • Duggan W; Pfizer Inc., Groton, CT, USA.
  • Sugg J; Astellas Pharma, Inc., Northbrook, IL, USA.
  • Russell D; Pfizer Inc., New York, NY, USA.
  • Beer TM; OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Eur J Cancer ; 170: 285-295, 2022 07.
Article em En | MEDLINE | ID: mdl-35643841
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Neoplasias de Próstata Resistentes à Castração / Metformina / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Neoplasias de Próstata Resistentes à Castração / Metformina / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article